Richard Stefanacci
Geriatric Medicine · Philadelphia, PANPI 1689748600
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2019 at $50,418 and has fallen 74.2% since, to $12,997 in 2025. Among geriatric medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $819.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$31K
- Merck$20K
- Sunovion Pharmaceuticals Inc.$20K
- Urovant Sciences Inc$18K
- Otsuka America Pharmaceutical, Inc.$10K
- Teva Pharmaceuticals USA, Inc.$8K
- plus $39K from 13 others
What the payments were for
- Consulting fees$62,22943%
- Speaking & faculty fees$64,42944%
- Travel & lodging$17,57912%
- Food & beverage$1,5881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $30,713 |
| Merck | 22 | $20,202 |
| Sunovion Pharmaceuticals Inc. | 38 | $19,781 |
| Urovant Sciences Inc | 33 | $18,023 |
| Otsuka America Pharmaceutical, Inc. | 7 | $10,315 |
| Teva Pharmaceuticals USA, Inc. | 10 | $8,046 |
| Genentech USA, Inc. | 7 | $7,506 |
| Sanofi-aventis U.S. LLC | 4 | $6,348 |
| Pfizer | 13 | $5,054 |
| UCB, Inc. | 1 | $4,400 |
| Sumitomo Pharma America, Inc. | 9 | $4,044 |
| Fisher Scientific Company L.L.C. | 2 | $3,700 |
| Eisai Inc. | 5 | $2,925 |
| Otter Pharmaceuticals, LLC | 1 | $1,491 |
| Biogen | 1 | $1,155 |
| Optinose US, Inc. | 9 | $1,027 |
| Johnson & Johnson | 1 | $720 |
| Acadia Pharmaceuticals Inc | 6 | $360 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$28,713
- GEMTESA$21,548
- LONHALA MAGNAIR$19,320
- Austedo XR$7,763
- REXULTI$5,830
- Dayvigo$2,775
- BRAHMS PCT KRYPTOR$2,500
- TOUJEO$2,284
- RELISTOR$2,000
- SOLIQUA 100/33$1,496
- SYMPAZAN$1,491
- PAXLOVID$1,400
- Procalcitonin$1,200
- Xhance$782
- XARELTO$720
- NUPLAZID$274
How this compares
$145,825 in reported general payments places this provider in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AranespDarbepoetin Alfa In Polysorbat | 17 | $41,953 |
| EliquisApixaban | 150 | $36,195 |
| OzempicSemaglutide | 24 | $24,078 |
| XareltoRivaroxaban | 37 | $19,702 |
| JardianceEmpagliflozin | 72 | $18,120 |
| TrulicityDulaglutide | 15 | $12,313 |
| Fluticasone-VilanterolFluticasone/Vilanterol | 23 | $8,660 |
| LumiganBimatoprost | 16 | $8,309 |
| LokelmaSodium Zirconium Cyclosilicate | 12 | $8,029 |
| Risperidone ErRisperidone Microspheres | 15 | $7,161 |
| Aripiprazole | 111 | $5,511 |
| FarxigaDapagliflozin Propanediol | 32 | $4,683 |
| Atorvastatin Calcium | 477 | $4,406 |
| Brimonidine Tartrate | 35 | $4,303 |
| JanuviaSitagliptin Phosphate | 24 | $4,236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $5,054 | $36,195150 claims |
| Johnson & JohnsonXarelto | $720 | $19,70237 claims |
| MerckJanuvia | $20,202 | $4,23624 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $4,044 | $1,96716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.
Other geriatric medicine in Philadelphia
- Michele ZaworaPhiladelphia$21K
- Jason KarlawishPhiladelphia$11K
- Ellen ZagrebelskyPhiladelphia$7K
- Katherine GalluzziPhiladelphia$7K
- Vladimir ZagrebelskyPhiladelphia$6K
- Lesley CarsonPhiladelphia$3K
- Helen VolokhonskyPhiladelphia$3K
- Jerry JohnsonPhiladelphia$2K
- Nicol JosephPhiladelphia$528
- James LinErie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.